Understanding vascular pathologies at the molecular level is of key importance to prevent or treat cardiovascular disease.

Maria Vivanco from Bilbao (CIC BioGune) will give the next TRAIL conference at the Institut Bergonié on Sept. 24th (starting time 2:30 p.m.) ”Breast cancer heterogeneity and resistance to endocrine therapy” Breast cancer is a heterogeneous disease, which in part arises from the existence of cells with stem-like properties (cancer stem/progenitor cells, CSCs). The identification and...

Maria Vivanco from Bilbao (CIC BioGune) will give the next TRAIL conference at the Institut Bergonié on Sept. 24th (starting time 2:30 p.m.) ”Breast cancer heterogeneity and resistance toendocrine therapy” Breast cancer is a heterogeneous disease, which inpart arises from the existence of cells with stem-likeproperties (cancer stem/progenitor cells, CSCs). Theidentification and characterisation...

Maria Vivanco from Bilbao (CIC BioGune) will give the next TRAIL conference at the Institut Bergonié on Sept. 24th (starting time 2:30 p.m.) ”Breast cancer heterogeneity and resistance toendocrine therapy” Breast cancer is a heterogeneous disease, which inpart arises from the existence of cells with stem-likeproperties (cancer stem/progenitor cells, CSCs). Theidentification and characterisation...

The next TRAIL Scientific day will be organized on September 16th (starting at 2 p.m.). It will be dedicated to Brain Connectivity with the interventions of notably 3 international speakers:> Prof. Iris-Katharina PENNER, Heinrich Heine University Düsseldorf, Department of Neurology> Dr. Menno SCHOONHEIM, Assistant Professor, VU University Medical Center, Department of Anatomy and Neurosciences >...

The project IMPACT (IMaging for Precision medicine within A Collaborative Translational program) has been submitted to the call for "Major research programs" (Grands programmes de recherche) of the University of Bordeaux. These Major Research programs are to be the backbone of the scientific excellence strategy of the University. More details about this action can be found here.